Anti-Infective Drugs Global Market Report 2022 – By Type (Antibiotics, Antivirals, Antifungals, Others (Anthelminthic, Antiprotozoal)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026

Starting Price : $5000.00 | Pages : 300 | Published : January 2022 | SKU CODE : r379 | Delivery Time: 2-3 business days | Format :


The anti-infective drugs market consists of sales of branded and generic anti-infective drugs and related services by entities (organizations, sole traders and partnerships) that manufacture branded or generic anti-infective drugs to treat microbial infections. The anti-infective drugs industry includes establishments that manufacture antibiotics to treat bacterial infections, anti-viral drugs to treat viral infections, anti-fungal drugs to treat fungal infections, anti-helminthic drugs to kill internal parasites, and antiprotozoal agents to treat protozoan infections.

The main types of anti-infective drugs are antibiotics, antivirals, antifungals and others (anthelminthic, antiprotozoal). Antibiotics are drugs that either kill or slow the growth of bacteria. The drugs are administered through oral, parenteral, and others that are classified into branded and generic drugs. The various mode of purchase includes prescription-based drugs and over-the-counter drugs which are distributed by hospital pharmacies, retail pharmacies/ drug stores, and others.

The global anti-infective drugs market size is expected to decline from $220.0 billion in 2021 to $246.80 billion in 2022 at a compound annual growth rate (CAGR) of 12.2%. The change in the anti-infective drugs market growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The anti-infective drugs market is expected to reach $614.29 billion in 2026 at a CAGR of 25.6%.

The anti-infective drugs market is expected to benefit from the latest developments in drug discovery procedures such as stem cells and organ-on-chip (OOC) technologies. OOCs are micro-engineered biometric systems that simulate the activities, mechanics and physiological responses of organ systems. Drug trial processes such as target identification, validation, and screening are being executed through OOC and stem cell technologies. These technologies are considerably reducing the drug discovery costs and generating reliable predictions on drug efficiency and human safety. Another area of development is physiology-simulation modelling, in which the integrated physiology of the human organism, in both health and disease, is simulated through a computer program. Eli Lilly and Pfizer have adopted Amazon’s Elastic Compute Cloud (EC2) platform to conduct simulation models in early stages of the drug discovery process that are operational within hours, whereas traditional models take weeks to conduct simulations. The wide adoption of these technologies is expected to drive the anti-infective drugs market in the forecast period.

The anti-infective drugs market is expected to be restrained by the increasing number of antimicrobial resistance cases due to growing ineffectiveness of conventional anti-infective drugs such as penicillin. Antimicrobial resistance is the final stage of the adaptation process of microorganisms such as bacteria to the environment developing the ability to resist the effects of anti-infective drugs. This is mainly caused by the overuse and misuse of anti-infective drugs such as antibiotics. The excessive use and misuse of anti-infective drugs increases the rate of the bacteria’s resistance, with an estimated 70% of bacteria ever discovered already being resistant to at least one anti-infective drug which was commonly used to treat them in the past. It is expected that deaths caused by antimicrobial resistance will rise to 10 million deaths by 2050. Increasing incidences of bacteria’s resistance to anti-infective drugs are expected to limit the use of anti-infective drugs, affecting the market’s growth.

Anti-infective drug manufacturers are investing in programs to develop drugs to treat drug resistant infections. Antimicrobial resistance is a serious concern to global public health as it resulted in long duration of illness, the requirement of additional tests and use of more expensive drugs. Antimicrobial resistance occurs when microorganisms such as bacteria, viruses, parasites and fungi change and adapted to drugs when they are exposed to antimicrobial drugs such as antibiotics, antivirals, antifungals, anthelmintics and others. According to World Health Organization (WHO), globally 4, 80,000 people are being affected by multi-drug resistant TB each year and drug resistance is starting to complicate the treatment of malaria and HIV as well. Companies are investing in developing the new drug candidates to treat drug-resistant infections. For instance, in 2019, the antibacterial agents imipenem, cilastatin and relebactam combination, pretomanid, lefamulin, and cefiderocol was approved by the US FDA in the field of resistant bacteria treatment for specific indications.

Major companies in the anti-infective drugs market include Gilead Sciences, GlaxosmithKline, Merck & Co, Johnson & Johnson, Pfizer Inc., AbbVie, Bayer AG, Mylan N.V., Shionogi and F. Hoffmann-La Roche Ltd.

North America was the largest region in the anti-infective drugs in 2021. The Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the anti-infective drugs market report are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela and Vietnam.

The global anti-infective drugs market is segmented -

1) By Type: Antibiotics, Antivirals, Antifungals, Others (Anthelminthic, Antiprotozoal)

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others

3) By Route of Administration: Oral, Parenteral, Others

4) By Drug Classification: Branded Drugs, Generic Drugs

5) By Mode of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs

    Table Of Contents

    1. Executive Summary

    2. Report Structure

    3. Anti-Infective Drugs Market Characteristics

    3.1. Market Definition

    3.2. Key Segmentations

    4. Anti-Infective Drugs Market Product Analysis

    4.1. Leading Products/ Services

    4.2. Key Features and Differentiators

    4.3. Development Products

    5. Anti-Infective Drugs Market Supply Chain

    5.1. Supply Chain

    5.2. Distribution

    5.3. End Customers

    6. Anti-Infective Drugs Market Customer Information

    6.1. Customer Preferences

    6.2. End Use Market Size and Growth

    7. Anti-Infective Drugs Market Trends And Strategies

    8. Impact Of COVID-19 On Anti-Infective Drugs

    9. Anti-Infective Drugs Market Size And Growth

    9.1. Market Size

    9.2. Historic Market Growth, Value ($ Billion)

    9.2.1. Drivers Of The Market

    9.2.2. Restraints On The Market

    9.3. Forecast Market Growth, Value ($ Billion)

    9.3.1. Drivers Of The Market

    9.3.2. Restraints On The Market

    10. Anti-Infective Drugs Market Regional Analysis

    10.1. Global Anti-Infective Drugs Market, 2021, By Region, Value ($ Billion)

    10.2. Global Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region

    10.3. Global Anti-Infective Drugs Market, Growth And Market Share Comparison, By Region

    11. Anti-Infective Drugs Market Segmentation

    11.1. Global Anti-Infective Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Antibiotics

    Antivirals

    Antifungals

    Others (Anthelminthic, Antiprotozoal)

    11.2. Global Anti-Infective Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies/ Drug Stores

    Others

    11.3. Global Anti-Infective Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Oral

    Parenteral

    Others

    11.4. Global Anti-Infective Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Branded Drugs

    Generic Drugs

    11.5. Global Anti-Infective Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Prescription-Based Drugs

    Over-The-Counter Drugs

    12. Anti-Infective Drugs Market Metrics

    12.1. Anti-Infective Drugs Market Size, Percentage Of GDP, 2016-2026, Global

    12.2. Per Capita Average Anti-Infective Drugs Market Expenditure, 2016-2026, Global

    13. Asia-Pacific Anti-Infective Drugs Market

    13.1. Asia-Pacific Anti-Infective Drugs Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    13.2. Asia-Pacific, Anti-Infective Drugs Market, 2021, By Country, Value ($ Billion)

    13.3. Asia-Pacific, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    13.4. Asia-Pacific, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    13.5. Asia-Pacific, Anti-Infective Drugs Market Metrics

    13.5.1. Per Capita Average Anti-Infective Drugs Expenditure, 2016-2026, Asia-Pacific Countries

    13.6. Asia-Pacific Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7. Asia-Pacific Anti-Infective Drugs Market: Country Analysis

    13.7.1. China Anti-Infective Drugs Market

    13.7.1.1. China Anti-Infective Drugs Market Overview

    13.7.1.2. China Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.1.3. China Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.2. Australia Anti-Infective Drugs Market

    13.7.2.1. Australia Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.2.2. Australia Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.3. Hong Kong Anti-Infective Drugs Market

    13.7.3.1. Hong Kong Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.4. India Anti-Infective Drugs Market

    13.7.4.1. India Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.4.2. India Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.5. Indonesia Anti-Infective Drugs Market

    13.7.5.1. Indonesia Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.5.2. Indonesia Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.6. Japan Anti-Infective Drugs Market

    13.7.6.1. Japan Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.6.2. Japan Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.7. Malaysia Anti-Infective Drugs Market

    13.7.7.1. Malaysia Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.8. New Zealand Anti-Infective Drugs Market

    13.7.8.1. New Zealand Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.9. Philippines Anti-Infective Drugs Market

    13.7.9.1. Philippines Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.10. Singapore Anti-Infective Drugs Market

    13.7.10.1. Singapore Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.11. South Korea Anti-Infective Drugs Market

    13.7.11.1. South Korea Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.11.2. South Korea Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.12. Thailand Anti-Infective Drugs Market

    13.7.12.1. Thailand Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    13.7.13. Vietnam Anti-Infective Drugs Market

    13.7.13.1. Vietnam Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14. Western Europe Anti-Infective Drugs Market

    14.1. Western Europe Anti-Infective Drugs Market Overview

    14.2. Western Europe, Anti-Infective Drugs Market, 2021, By Country, Value ($ Billion)

    14.3. Western Europe, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    14.4. Western Europe, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    14.5. Western Europe, Anti-Infective Drugs Market Metrics

    14.5.1. Per Capita Average Anti-Infective Drugs Expenditure, 2016-2026, Western Europe Countries

    14.6. Western Europe Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7. Western Europe Anti-Infective Drugs Market: Country Analysis

    14.7.1. Austria Anti-Infective Drugs Market

    14.7.1.1. Austria Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.2. Belgium Anti-Infective Drugs Market

    14.7.2.1. Belgium Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.3. Denmark Anti-Infective Drugs Market

    14.7.3.1. Denmark Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.4. Finland Anti-Infective Drugs Market

    14.7.4.1. Finland Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.5. France Anti-Infective Drugs Market

    14.7.5.1. France Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.5.2. France Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.6. Germany Anti-Infective Drugs Market

    14.7.6.1. Germany Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.6.2. Germany Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.7. Ireland Anti-Infective Drugs Market

    14.7.7.1. Ireland Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.8. Italy Anti-Infective Drugs Market

    14.7.8.1. Italy Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.9. Netherlands Anti-Infective Drugs Market

    14.7.9.1. Netherlands Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.10. Norway Anti-Infective Drugs Market

    14.7.10.1. Norway Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.11. Portugal Anti-Infective Drugs Market

    14.7.11.1. Portugal Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.12. Spain Anti-Infective Drugs Market

    14.7.12.1. Spain Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.13. Sweden Anti-Infective Drugs Market

    14.7.13.1. Sweden Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.14. Switzerland Anti-Infective Drugs Market

    14.7.14.1. Switzerland Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.15. UK Anti-Infective Drugs Market

    14.7.15.1. UK Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    14.7.15.2. UK Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    15. Eastern Europe Anti-Infective Drugs Market

    15.1. Eastern Europe Anti-Infective Drugs Market Overview

    15.2. Eastern Europe, Anti-Infective Drugs Market, 2021, By Country, Value ($ Billion)

    15.3. Eastern Europe, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    15.4. Eastern Europe, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    15.5. Eastern Europe, Anti-Infective Drugs Market Metrics

    15.5.1. Per Capita Average Anti-Infective Drugs Expenditure, 2016-2026, Eastern Europe Countries

    15.6. Eastern Europe Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    15.7. Eastern Europe Anti-Infective Drugs Market: Country Analysis

    15.7.1. Czech Republic Anti-Infective Drugs Market,  

    15.7.1.1. Czech Republic Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    15.7.2. Poland Anti-Infective Drugs Market

    15.7.2.1. Poland Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    15.7.3. Romania Anti-Infective Drugs Market

    15.7.3.1. Romania Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    15.7.4. Russia Anti-Infective Drugs Market

    15.7.4.1. Russia Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    15.7.4.2. Russia Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    16. North America Anti-Infective Drugs Market

    16.1. North America Anti-Infective Drugs Market Overview

    16.2. North America, Anti-Infective Drugs Market, 2021, By Country, Value ($ Billion)

    16.3. North America, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    16.4. North America, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    16.5. North America, Anti-Infective Drugs Market Metrics

    16.5.1. Per Capita Average Anti-Infective Drugs Expenditure, 2016-2026, North America Countries

    16.6. North America Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    16.7. North America Anti-Infective Drugs Market: Country Analysis

    16.7.1. Canada Anti-Infective Drugs Market

    16.7.1.1. Canada Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    16.7.2. Mexico Anti-Infective Drugs Market

    16.7.2.1. Mexico Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    16.7.3. USA Anti-Infective Drugs Market

    16.7.3.1. USA Anti-Infective Drugs Market Overview

    16.7.3.2. USA Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    16.7.3.3. USA Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17. South America Anti-Infective Drugs Market

    17.1. South America Anti-Infective Drugs Market Overview

    17.2. South America, Anti-Infective Drugs Market, 2021, By Country, Value ($ Billion)

    17.3. South America, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    17.4. South America, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    17.5. South America, Anti-Infective Drugs Market Metrics

    17.5.1. Per Capita Average Anti-Infective Drugs Expenditure, 2016-2026, South America Countries

    17.6. South America Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7. South America Anti-Infective Drugs Market: Country Analysis

    17.7.1. Argentina Anti-Infective Drugs Market

    17.7.1.1. Argentina Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7.2. Brazil Anti-Infective Drugs Market

    17.7.1.1. Brazil Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7.2.2. Brazil Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7.3. Chile Anti-Infective Drugs Market

    17.7.3.1. Chile Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7.4. Colombia Anti-Infective Drugs Market

    17.7.4.1. Colombia Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7.5. Peru Anti-Infective Drugs Market

    17.7.5.1. Peru Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    17.7.6. Venezuela Anti-Infective Drugs Market

    17.7.6.1. Venezuela Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    18. Middle East Anti-Infective Drugs Market

    18.1. Middle East Anti-Infective Drugs Market Overview

    18.2. Middle East, Anti-Infective Drugs Market, 2021, By Country, Value ($ Billion)

    18.3. Middle East, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    18.4. Middle East, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    18.5. Middle East, Anti-Infective Drugs Market Metrics

    18.5.1. Per Capita Average Anti-Infective Drugs Expenditure, 2016-2026, Middle East Countries

    18.6. Middle East Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    18.7. Middle East Anti-Infective Drugs Market: Country Analysis

    18.7.1. Saudi Arabia Anti-Infective Drugs Market

    18.7.1.1. Saudi Arabia Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    18.7.2. Israel Anti-Infective Drugs Market

    18.7.2.1. Israel Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    18.7.3. Turkey Anti-Infective Drugs Market

    18.7.3.1. Turkey Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    18.7.4. UAE Anti-Infective Drugs Market

    18.7.4.1. UAE Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    19. Africa Anti-Infective Drugs Market

    19.1. Africa Anti-Infective Drugs Market Overview

    19.2. Africa, Anti-Infective Drugs Market, 2021, By Country, Value ($ Billion)

    19.3. Africa, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

    19.4. Africa, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

    19.5. Africa, Anti-Infective Drugs Market Metrics

    19.5.1. Per Capita Average Anti-Infective Drugs Expenditure, 2016-2026, Africa Countries

    19.6. Africa Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    19.7. Africa Anti-Infective Drugs Market: Country Analysis

    19.7.1. Egypt Anti-Infective Drugs Market

    19.7.1.1. Egypt Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    19.7.2. Nigeria Anti-Infective Drugs Market

    19.7.2.1. Nigeria Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    19.7.3. South Africa Anti-Infective Drugs Market

    19.7.3.1. South Africa Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

    20. Anti-Infective Drugs Market Competitive Landscape

    20.1. Competitive Market Overview

    20.2. Market Shares

    20.3. Company Profiles

    20.3.1. Gilead Sciences

    20.3.1.1. Company Overview

    20.3.1.2. Products And Services

    20.3.1.3. Strategy

    20.3.1.4. Financial Performance

    20.3.2. GlaxosmithKline

    20.3.2.1. Company Overview

    20.3.2.2. Products And Services

    20.3.2.3. Strategy

    20.3.2.4. Financial Performance

    20.3.3. Merck & Co

    20.3.3.1. Company Overview

    20.3.3.2. Products And Services

    20.3.3.3. Strategy

    20.3.3.4. Financial Performance

    20.3.4. Johnson & Johnson

    20.3.4.1. Company Overview

    20.3.4.2. Products And Services

    20.3.4.3. Strategy

    20.3.4.4. Financial Performance

    20.3.5. Pfizer Inc

    20.3.5.1. Company Overview

    20.3.5.2. Products And Services

    20.3.5.3. Strategy

    20.3.5.4. Financial Performance

    21. Key Mergers And Acquisitions In The Anti-Infective Drugs Market

    22. Market Background: Pharmaceutical Drugs Market

    22.1. Pharmaceutical Drugs Market Characteristics

    22.2. Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F Growth, By Segment, Value ($ Billion), Global

    22.3. Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)

    22.4. Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region

    22.5. Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)

    23. Recommendations

    23.1. Global Anti-Infective Drugs Market In 2026- Growth Countries

    23.2. Global Anti-Infective Drugs Market In 2026- Growth Segments

    23.3. Global Anti-Infective Drugs Market In 2026- Growth Strategies

    24. Appendix

    24.1. NAICS Definitions Of Industry Covered In This Report

    24.2. Abbreviations

    24.3. Currencies

    24.4. Research Inquiries

    24.5. The Business Research Company

    25. Copyright And Disclaimer

List Of Tables

    Table 1: Historic Market Growth, Value ($ Billion)
  • Table 2: Forecast Market Growth, Value ($ Billion)
  • Table 3: Global Anti-Infective Drugs Market, 2021, By Region, Value ($ Billion)
  • Table 4: Global Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Table 5: Global Anti-Infective Drugs Market, Growth And Market Share Comparison, By Region
  • Table 6: Global Anti-Infective Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 7: Global Anti-Infective Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 8: Global Anti-Infective Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 9: Global Anti-Infective Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 10: Global Anti-Infective Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 11: Anti-Infective Drugs Market Size, Percentage Of GDP, 2016-2026, Global
  • Table 12: Per Capita Average Anti-Infective Drugs Market Expenditure, 2016-2026, Global
  • Table 13: Asia-Pacific, Anti-Infective Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 14: Asia-Pacific, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 15: Asia-Pacific, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 16: Per Capita Average Anti-Infective Drugs Expenditure, 2016-2026, Asia-Pacific Countries
  • Table 17: Asia-Pacific Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 18: China Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 19: China Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 20: Australia Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 21: Australia Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 22: Hong Kong Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 23: India Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 24: India Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 25: Indonesia Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 26: Indonesia Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 27: Japan Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 28: Japan Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 29: Malaysia Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 30: New Zealand Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 31: Philippines Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 32: Singapore Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 33: South Korea Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 34: Thailand Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 35: Vietnam Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 36: Western Europe, Anti-Infective Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 37: Western Europe, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 38: Western Europe, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 39: Per Capita Average Anti-Infective Drugs Expenditure, 2016-2026, Western Europe Countries
  • Table 40: Western Europe Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 41: Austria Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 42: Belgium Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 43: Denmark Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 44: Finland Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 45: France Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 46: France Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 47: Germany Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 48: Germany Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 49: Ireland Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 50: Italy Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 51: Netherlands Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 52: Norway Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 53: Portugal Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 54: Spain Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 55: Sweden Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 56: Switzerland Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 57: UK Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 58: UK Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 59: Eastern Europe, Anti-Infective Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 60: Eastern Europe, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 61: Eastern Europe, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 62: Per Capita Average Anti-Infective Drugs Expenditure, 2016-2026, Eastern Europe Countries
  • Table 63: Eastern Europe Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 64: Czech Republic Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 65: Poland Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 66: Romania Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 67: Russia Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 68: Russia Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 69: North America, Anti-Infective Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 70: North America, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 71: North America, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 72: Per Capita Average Anti-Infective Drugs Expenditure, 2016-2026, North America Countries
  • Table 73: North America Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 74: Canada Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 75: Mexico Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 76: USA Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 77: USA Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 78: South America, Anti-Infective Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 79: South America, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 80: South America, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 81: Per Capita Average Anti-Infective Drugs Expenditure, 2016-2026, South America Countries
  • Table 82: South America Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 83: Argentina Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 84: Brazil Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 85: Brazil Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 86: Chile Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 87: Colombia Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 88: Peru Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 89: Venezuela Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 90: Middle East, Anti-Infective Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 91: Middle East, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 92: Middle East, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 93: Per Capita Average Anti-Infective Drugs Expenditure, 2016-2026, Middle East Countries
  • Table 94: Middle East Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 95: Saudi Arabia Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 96: Israel Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 97: Turkey Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 98: UAE Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 99: Africa, Anti-Infective Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 100: Africa, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 101: Africa, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 102: Per Capita Average Anti-Infective Drugs Expenditure, 2016-2026, Africa Countries
  • Table 103: Africa Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 104: Egypt Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 105: Nigeria Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 106: South Africa Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 107: Gilead Financial Performance
  • Table 108: GlaxosmithKline Financial Performance
  • Table 109: Merck & Co Financial Performance
  • Table 110: Johnson & Johnson Financial Performance
  • Table 111: Pfizer Inc Financial Performance
  • Table 112: Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F, Growth, By Segment, Value ($ Billion), Global
  • Table 113: Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)
  • Table 114: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Table 115: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)
  • Table 116: Global Anti-Infective Drugs Market In 2026- Growth Countries
  • Table 117: Global Anti-Infective Drugs Market In 2026- Growth Segments
  • Table 118: Global Anti-Infective Drugs Market In 2026- Growth Strategies

List Of Figures

    Figure 1: Historic Market Growth, Value ($ Billion)
  • Figure 2: Forecast Market Growth, Value ($ Billion)
  • Figure 3: Global Anti-Infective Drugs Market, 2021, By Region, Value ($ Billion)
  • Figure 4: Global Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Figure 5: Global Anti-Infective Drugs Market, Growth And Market Share Comparison, By Region
  • Figure 6: Global Anti-Infective Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 7: Global Anti-Infective Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 8: Global Anti-Infective Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 9: Global Anti-Infective Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 10: Global Anti-Infective Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 11: Anti-Infective Drugs Market Size, Percentage Of GDP, 2016-2026, Global
  • Figure 12: Per Capita Average Anti-Infective Drugs Market Expenditure, 2016-2026, Global
  • Figure 13: Asia-Pacific, Anti-Infective Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 14: Asia-Pacific, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 15: Asia-Pacific, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 16: Per Capita Average Anti-Infective Drugs Expenditure, 2016-2026, Asia-Pacific Countries
  • Figure 17: Asia-Pacific Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 18: China Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 19: China Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 20: Australia Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 21: Australia Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 22: Hong Kong Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 23: India Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 24: India Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 25: Indonesia Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 26: Indonesia Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 27: Japan Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 28: Japan Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 29: Malaysia Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 30: New Zealand Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 31: Philippines Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 32: Singapore Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 33: South Korea Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 34: Thailand Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 35: Vietnam Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 36: Western Europe, Anti-Infective Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 37: Western Europe, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 38: Western Europe, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 39: Per Capita Average Anti-Infective Drugs Expenditure, 2016-2026, Western Europe Countries
  • Figure 40: Western Europe Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 41: Austria Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 42: Belgium Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 43: Denmark Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 44: Finland Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 45: France Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 46: France Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 47: Germany Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 48: Germany Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 49: Ireland Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 50: Italy Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 51: Netherlands Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 52: Norway Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 53: Portugal Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 54: Spain Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 55: Sweden Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 56: Switzerland Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 57: UK Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 58: UK Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 59: Eastern Europe, Anti-Infective Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 60: Eastern Europe, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 61: Eastern Europe, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 62: Per Capita Average Anti-Infective Drugs Expenditure, 2016-2026, Eastern Europe Countries
  • Figure 63: Eastern Europe Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 64: Czech Republic Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 65: Poland Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 66: Romania Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 67: Russia Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 68: Russia Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 69: North America, Anti-Infective Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 70: North America, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 71: North America, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 72: Per Capita Average Anti-Infective Drugs Expenditure, 2016-2026, North America Countries
  • Figure 73: North America Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 74: Canada Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 75: Mexico Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 76: USA Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 77: USA Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 78: South America, Anti-Infective Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 79: South America, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 80: South America, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 81: Per Capita Average Anti-Infective Drugs Expenditure, 2016-2026, South America Countries
  • Figure 82: South America Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 83: Argentina Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 84: Brazil Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 85: Brazil Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 86: Chile Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 87: Colombia Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 88: Peru Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 89: Venezuela Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 90: Middle East, Anti-Infective Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 91: Middle East, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 92: Middle East, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 93: Per Capita Average Anti-Infective Drugs Expenditure, 2016-2026, Middle East Countries
  • Figure 94: Middle East Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 95: Saudi Arabia Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 96: Israel Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 97: Turkey Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 98: UAE Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 99: Africa, Anti-Infective Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 100: Africa, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 101: Africa, Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 102: Per Capita Average Anti-Infective Drugs Expenditure, 2016-2026, Africa Countries
  • Figure 103: Africa Anti-Infective Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 104: Egypt Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 105: Nigeria Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 106: South Africa Anti-Infective Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 107: Gilead Financial Performance
  • Figure 108: GlaxosmithKline Financial Performance
  • Figure 109: Merck & Co Financial Performance
  • Figure 110: Johnson & Johnson Financial Performance
  • Figure 111: Pfizer Inc Financial Performance
  • Figure 112: Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F, Growth, By Segment, Value ($ Billion), Global
  • Figure 113: Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)
  • Figure 114: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Figure 115: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)
  • Figure 116: Global Anti-Infective Drugs Market In 2026- Growth Countries
  • Figure 117: Global Anti-Infective Drugs Market In 2026- Growth Segments
  • Figure 118: Global Anti-Infective Drugs Market In 2026- Growth Strategies
Global Anti-Infective Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cell and Gene Therapy Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Pharmaceutical Drugs And Biologics Logistics Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Pharmaceutical Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Microbiome Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global G-CSF (Granulocyte Colony Stimulating Factors) Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Therapeutic Proteins Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
COVID-19 Drug Associated APIs Global Market Report 2021 - By Drug Class (Antimalarials, Bronchodilators, Antibiotics, Antivirals), COVID-19 Growth And Change
View Report
Ambulatory IV Infusion Pumps Market 2022 - By Therapy (Infusion Pumps, Anti-Infective Infusion Pump), By Patient Care Settings (Hospitals, Home Healthcare), By Application (Chemotherapy/Oncology, Diabetes, Gastroenterology, Analgesia/Pain Management, Pediatrics/Neonatology, Hematology, Anti-Infective), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Vaccines Global Market Report 2022 – By Type (Anti-Infective Vaccines, Autoimmunity, Others (Cancer And Others)), By Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines), By Route of Administration (Intramuscular (IM), Subcutaneous (SC), Oral, Others), By Valance (Monovalent, Multivalent), By Distribution Channel (Institutional Sale, Hospital Pharmacies, Retail Pharmacies) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Cough And Cold Preparations Global Market Report 2021 - By Drug Type (Antihistamines, Expectorants, Bronchodilators, Decongestants, Antibiotics), By Dosage Type (Oral Syrups, Tablets/Pills, Nasal Drops, Lozenges), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores), COVID-19 Implications And Growth
View Report
Antivirals Global Market Report 2021 - By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors), By Application (HIV, Hepatitis, Herpes, Influenza), By Type (Branded, Generic), COVID-19 Implications And Growth
View Report
Antifungals Global Market Report 2021 - By Drug Type (Echinocandins, Azoles, Polyenes, Allylamines), By End Users (Hospitals & Clinics, Dermatology Clinics), By Route of Administration (Oral, Parenteral, Topical), By Therapeutic Indications (Aspergillosis, Dermatophytosis, Candidiasis), COVID-19 Impact and Recovery
View Report
Monoclonal Antibodies (MAbS) Global Market Report 2021 - By Source (Murine, Chimeric, Humanized, Human), By Application (Anti-Cancer, Immunological, Anti-Infective Monoclonal Antibodies (MAbs), Neuropharmacological, Cardiovascular And Cerebrovascular), By End Users (Hospitals, Private Clinics, Research Institute), COVID-19 Impact And Recovery
View Report
Pharmaceutical Drugs And Biologics Logistics Market 2021 - By Type Of Service (Cold Chain Logistics, Non-Cold Chain Logistics), By Mode Of Transport (Air Transportation, Ocean Transportation, Land Transportation), By Pharmaceutical Type (Pharmaceutical Drugs, Biologics), By Therapeutic Area (Metabolic Disorders Drugs, Anti-Infective Drugs, Central Nervous System Drugs, Respiratory Diseases Drugs, Cardiovascular Drugs, Musculoskeletal Disorders Drugs, Oncology Drugs, Hematology Drugs, Monoclonal Antibodies (MAbS), Genito-Urinary Drugs, Gastrointestinal Drugs, Therapeutic Proteins, Dermatology Drugs, Vaccines, Ophthalmology Drugs), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)